Neuroscience and Behavioral Physiology

, Volume 30, Issue 2, pp 225–229 | Cite as

Improvements in the selective perception and training of rats using an original analog of the C-terminal fragment of vasopressin

  • N. S. Ponomareva
  • O. G. Voskresenskaya
  • A. A. Kamenskii
  • V. P. Golubovich
  • I. P. Ashmarin
Article

Abstract

This report presents studies on the effects of intranasal administration of five doses (0.001, 0.01, 0.1, 1, and 10 μg/kg) of a new analog of arginine-vasopressin fragment AVP(6–9), i.e., D-MPRG, on the learning ability of rats with positive and negative reinforcement. All doses of the peptide improved learning. The most effective dose was 0.01 μg/kg, at which the peptide accelerated the acquisition of a conditioned active avoidance reflex both when given 1 h before and when given immediately after training sessions. The peptide had greater effects when animals were trained with negative reinforcement. Analysis of the results suggests that the action of D-MPRG is mainly on perception processes, i.e., extraction of the conditioned stimulus from the environmental surroundings and evaluation and enhancement of its biological significance. In addition, this peptide prevented extinction of the acquired habit and improved the processes of consolidation, though this effect was weaker than its effect on perception.

Key Words

Memory learning vasopressin fragment analog 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    USSR Patent No. 1623166, 22 September 1990.Google Scholar
  2. 2.
    S. A. Titov, “The neurochemical bases of memory,” in:Neurochemistry [in Russian], I. P. Ashmarin and P. I. Stukalov (Eds.), Institute of Biomedical Chemistry Press, Russian Academy of Medical Sciences, Moscow (1996), pp. 372–414.Google Scholar
  3. 3.
    V. P. Golubovich, P. V. Martinovich, A. B. Usenko, L. K. Slobodchikova, S. A. Titov, and I. P. Ashmarin, “Synthesis and biological activity of C-terminal fragments of vasopressin,”Khim. Farm. Zh.,6, 675–679 (1988).Google Scholar
  4. 4.
    J. P. H. Burbach, G. L. Kovasc, D. de Wied, J. W. van Nispen, and H. M. Greven, “A major metabolite of arginine vasopressin in the brain is a highly potent neuropeptide,”Science,221, No. 4617, 1310–1312 (1983).PubMedGoogle Scholar
  5. 5.
    H. Car, M. Borawska, and K. Wisniewsky, “The effect of vasopressin analog: [d(CH2)1 5 Tyr(Me)2, δ3Pro7]AVP on learning and memory processes in rats with experimental amnesia,”Pol. J. Pharmacol.,45, 11–22 (1993).PubMedGoogle Scholar
  6. 6.
    D. de Wied and W. H. Gispen, “Behavioral effects of peptides,” in:Peptides in Neurobiology, H. Jainer (Ed.), Bethesda (1977), pp. 397–425.Google Scholar
  7. 7.
    D. de Wied, “Vasopressin and memory processes,” in:Abstracts of 31st Int. Congress Physiol. Sci. Helsinki, 9–14 July 1989, p. 249.Google Scholar
  8. 8.
    S. N. Deyo, W. J. Shoemaker, A. Ettenberg, F. E. Bloom, and G. F. Koob, “Subcutaneous administration of behaviourally effective doses of arginine vasopressin change brain AVP content only in median eminence,”Neuroendocrinology,42, No. 3, 260–266 (1986).PubMedGoogle Scholar
  9. 9.
    J. J. Legros and M. Timsit-Berthier, “Vasopressin and vasopressin analogues for treatment of memory disorders in clinical practice,”Prog. Neuro-Psychopharmacol. Biol. Psychiatry,12, 571–586 (1988).Google Scholar
  10. 10.
    C. Lin, Y. C. Du, and R. Y. Liu, “Cysteinyl methyl ester of AVP(4–8), a potent agonist, on the maintenance of passive avoidance in rats,”Peptides,11, No. 4, 633–639 (1990).PubMedCrossRefGoogle Scholar
  11. 11.
    K. S. E. Su, K. M. Campanale, L. G. Mendelsohn, G. A. Kerchner, and C. L. Gries, “Nasal delivery of polypeptides. I. Nasal absorption of enkephalins in rats,”J. Pharm. Sci.,74, No. 4, 394–398 (1985).PubMedGoogle Scholar
  12. 12.
    R. Wan, D. de Wied, W. de Jong, and M. Diamant, “Differential effects of ACTH(4–10), DG-AVP and DG-OXT on heart and passive avoidance behavior in rats,”Physiol. Behav.,51, No. 3, 507–513 (1992).PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic/Plenum Publishers 2000

Authors and Affiliations

  • N. S. Ponomareva
    • 1
  • O. G. Voskresenskaya
    • 1
  • A. A. Kamenskii
    • 1
  • V. P. Golubovich
    • 2
  • I. P. Ashmarin
    • 1
  1. 1.M. V. Lomonosov Moscow State UniversityMoscowRussia
  2. 2.Institute of Bioorganic ChemistryBelarus Academy of SciencesMinskBelarus

Personalised recommendations